We are soliciting applications from investigators for Innovator Awards to be used for understanding disease mechanisms and the identification and pre-clinical testing of therapies to prevent or reverse all forms of hydrocephalus. The goal of this initiative is to provide seed funding for bold and innovative research with the potential to transform the field of hydrocephalus through the understanding of disease mechanisms and the development of novel therapies. This award is not intended to support human trials, the development of medical devices, instrumentation, or other commercial applications, nor is it intended to support the development of new animal or ex vivo models of hydrocephalus for the purpose of future research.
The award provides short term seed funding for up to 12 months. Proposals may be submitted for actual costs at one of two funding levels, $25,000 or $50,000. Total funding through this RFA will not exceed $200,000. The number of awards made will depend on the quality of the applications received and the research priorities determined by the Hydrocephalus Association. The Hydrocephalus Association will accept applications from researchers based at accredited non-profit research and academic institutions throughout the world. The award provides no institutional overhead. All applications must be submitted in English. In upcoming years, the Hydrocephalus Association anticipates a follow-on RFA for multiyear support.
LOI Due: June 7, 2015
Full Applications Due: August 3, 2015
Applicants must sign up to the Hydrocephalus Association Network for Discovery Science (HANDS) to view the LOI. Sign up is free!